A New Dietary Approach to Reduce the Risk of Type 2 Diabetes?

Diabetes Care

Volumn 27, Issue 1, 2004, Pages 270-271

  Nadler, Jerry L ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MAGNESIUM;

ADULT; ANIMAL MODEL; BODY MASS; DIABETES MELLITUS; DIET SUPPLEMENTATION; DIETARY INTAKE; EDITORIAL; FEMALE; GRAIN; HIGH RISK POPULATION; HUMAN; LEAFY VEGETABLE; MAGNESIUM DEFICIENCY; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; NUT; RAT;

DIABETES MELLITUS, TYPE 2; DIET; HUMANS; INCIDENCE; LIFE STYLE; RISK FACTORS;

EID: 1042280180     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.27.1.270     Document Type: Editorial

References (21)

1. Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, Nathan DM: Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346:393-403, 2002
2. Lopez-Ridaura R, Willett WC, Rimm EB, Liu S, Stampfer MJ, Manson JE, Hu FB: Magnesium intake and risk of type 2 diabetes in men and women. Diabetes Care 27:134-140, 2003
3. Song Y, Manson ME, Buring JE, Liu S: Dietary magnesium intake in relation to plasma insulin levels and risk of type 2 diabetes in women. Diabetes Care 27:59-65, 2003.
4. Meyer KA, Kushi LH, Jacobs DR Jr, Slavin J, Sellers TA, Folsom AR: Carbohydrates, dietary fiber, and incident type 2 diabetes in older women. Am J Clin Nutr 71:921-930, 2000
5. McKeown NM, Meigs JB, Liu S, Wilson PW, Jacques PF: Whole-grain intake is favorably associated with metabolic risk factors for type 2 diabetes and cardiovascular disease in the Framingham Offspring Study. Am J Clin Nutr 76:390-398, 2002
6. Abbott RD, Ando F, Masaki KH, Tung KH, Rodriguez BL, Petrovitch H, Yano K, Curb JD: Dietary magnesium intake and the future risk of coronary heart disease: the Honolulu Heart Program. Am J Cardiol 92:665-669, 2003
7. Ma J, Folsom AR, Melnick SL, Eckfeldt JH, Sharrett AR, Nabulsi AA, Hutchinson RG, Metcalf PA: Associations of serum and dietary magnesium with cardiovascular disease, hypertension, diabetes, insulin, and carotid arterial wall thickness: the ARIC study: Atherosclerosis Risk in Communities Study. J Clin Epidemiol 48:927-940, 1995
8. Kao WH, Folsom AR, Nieto FJ, Mo JP, Watson RL, Brancati FL: Serum and dietary magnesium and the risk for type 2 diabetes mellitus: the Atherosclerosis Risk in Communities Study. Arch Intern Med 159:2151-2159, 1999
9. Kandeel FR, Balon E, Scott S, Nadler JL: Magnesium deficiency and glucose metabolism in rat adipocytes. Metabolism 45:838-843, 1996
10. Suarez A, Pulido N, Casla A, Casanova B, Arrieta FJ, Rovira A: Impaired tyrosine-kinase activity of muscle insulin receptors from hypomagnesaemic rats. Diabetologia 38:1262-1270, 1995
11. Nadler JL, Buchanan T, Natarajan R, Antonipillai I, Bergman R, Rude R: Magnesium deficiency produces insulin resistance and increased thromboxane synthesis. Hypertension 21:1024-1029, 1993
12. Humphries S, Kushner H, Falkner B: Low dietary magnesium is associated with insulin resistance in a sample of young, nondiabetic Black Americans. Am J Hypertens 12:747-756, 1999
13. Rosolova H, Mayer O Jr, Reaven G: Effect of variations in plasma magnesium concentration on resistance to insulin-mediated glucose disposal in nondiabetic subjects. J Clin Endocrinol Metab 82:3783-3785, 1997
14. Resnick LM: Ionic basis of hypertension, insulin resistance, vascular disease, and related disorders: mechanism of syndrome X. Am J Hypertens 6:123S-134S, 1993
15. Sowers JR, Draznin B: Insulin, cation metabolism and insulin resistance. J Basic Clin Physiol Pharmacol 9:223-233, 1998
16. Barbagallo M, Dominguez LJ, Galiot A, Ferlisi A, Cani C, Malfa L, Pineo A, Busardo A, Paolisso G: Role of magnesium in insulin action, diabetes and cardio-metabolic syndrome X. Molecular Aspects Med 24:39-52, 2003
17. Balon TW, Jasman A, Scott S, Meehan WP, Rude RK, Nadler JL: Dietary magnesium prevents fructose-induced insulin insensitivity in rats. Hypertension 23:1036-1039, 1994
18. Balon TW, Gu JL, Tokuyama Y, Jasman AP, Nadler JL: Magnesium supplementation reduces development of diabetes in a rat model of spontaneous NIDDM. Am J Physiol 269:E745-E752, 1995
19. Paolisso G, Scheen A, Cozzolino D, Di Marco G, Varricchio M, D'Onofrio F, Lefebvre PJ: Changes in glucose turnover parameters and improvement of glucose oxidation after 4-week magnesium administration in elderly noninsulin-dependent (type II) diabetic patients. J Clin Endocrinol Metab 78:1510-1514, 1994
20. Lima MD, Cruz T, Pousada JC, Rodrigues LE, Barbosa K, Cangucu V: The effect of magnesium supplementation in increasing doses on the control of type 2 diabetes. Diabetes Care 21:682-686, 1998
21. Rodríguez-Morán M, Guerrero-Romero F: Oral magnesium supplementation improves insulin sensitivity and metabolic control in type 2 diabetic subjects. Diabetes Care 26:1147-1152, 2003